News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
The association of oncogene driver mutations with recurrence and survival in stage I NSCLC
Daniel M. Libby
Dec 25, 2024, 09:42

The association of oncogene driver mutations with recurrence and survival in stage I NSCLC

Clinical Lung Cancer shared an article by Daniel M. Libby on X:

“Explore a new article evaluating the association of oncogene driver mutations with recurrence and survival in stage I non-small cell lung cancer (NSCLC).”

The association of oncogene driver mutations with recurrence and survival in stage I NSCLC

Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Non-small Cell Lung Cancer.

Authors: Daniel M. Libby, et al.

The association of oncogene driver mutations with recurrence and survival in stage I NSCLC

cancer Clinical Lung Cancer Daniel M. Libby fight against cancer Global fight against cancer non small cell lung cancer NSCLC OncoDaily oncogene Oncology
Special Coverage
Blog
Mar 31, 2025, 08:24
Boost your career with ESTRO 2025
Blog
Mar 31, 2025, 08:09
Emily Drake: Mapping organizations that serve solely the pediatric oncology community in Canada
Blog
Mar 31, 2025, 08:01
Prof. Keith Kerr: Advancing Lung Cancer Pathology – 2025 Heine H. Hansen Award
Blog
Mar 31, 2025, 07:56
Advances in KRAS G12C-Mutated NSCLC: Key Insights from ELCC 2025
Blog
Mar 31, 2025, 07:41
Sendurai Mani: Reflecting on Many Chapters of Life: A Powerful TEDx Talk by John Tarantino
Blog
Mar 31, 2025, 06:10
The lung cancer patient advocacy sessions at the ELCC 2025 were standout events - Lung Cancer Europe
Insight
Mar 31, 2025, 06:04
Yan Leyfman: Expanding Antibody Therapeutics with TCR Mimicry 
Blog
Mar 31, 2025, 05:50
Jennifer Bires: Proud to speak on AI and mental health at NCCS Cancer Advocacy’s Spring 2025 Cancer Policy Roundtable
Insight
Mar 31, 2025, 05:03
Jarushka Naidoo: My ELCC 2025 Top 3 - MARIPOSA, KRYSTAL7 and Deescalation trials
Blog
Mar 31, 2025, 04:59
Michael Sapienza: Federal funding for cancer and other disease research has been cut by more than $1 billion
Blog
Mar 31, 2025, 04:45
Amil Družić: Excited to be part of the upcoming Young Cancer Professionals Roundtable
Blog
Mar 31, 2025, 03:27
Inside Cancer Careers Podcast Concluding – Thank You to our guests and listeners for two incredible years: Train at NCI